Skip to main content

Search

Join Our Contact Registry

RDCRN Alumni badge

Header Social Media

Main navigation

Our Research
Researchers and Clinicians
Patient and Families
Early Stage Investigators
News and Events
About Us
Podcast
- PIDTC Podcast

A Previously-Funded NIH Rare Diseases Clinical Research Network Consortium

PIDTC Newsletters

PIDTC Updates

Newsletter of the Primary Immune Deficiency Treatment Consortium

| Sep 2026

Issue 24 | Summer

Learn More

Newsletter Image

Join Our Email List

Dec 2020 | Issue 12 | Winter

May 2020 | Issue 11 | Spring

Nov 2019 | Issue 10 | Fall

Jun 2019 | Issue 09 | Summer

Jan 2019 | Issue 08 | Winter

Aug 2017 | Issue 06 | Summer

Apr 2017 | Issue 05 | Spring

Dec 2016 | Issue 04 | Winter

Aug 2016 | Issue 03 | Summer

Apr 2016 | Issue 02 | Spring

Load More

Footer menu

Web Policies
Genetic and Rare Diseases Information Center
Members Login
Contact Us

The Primary Immune Deficiency Treatment Consortium (PIDTC) is a previously funded research group of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). PIDTC received funding under grant number U54AI082973 as a collaboration between NCATS and the National Institute of Allergy and Infectious Diseases (NIAID). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke NINDS) under grant number TR002818. The content of this website is solely the responsibility of the PIDTC administrative coordinating center at University of California, San Francisco and does not necessarily represent the official views of the NIH.

social media